Firm launches 24 health supply chain innovators

Healthcare consulting firm, Salient Advisory, has launched its latest market intelligence report, focusing on 24 leading Africa-focused supply chain innovators, which appear to be on the cusp of more substantive impact.

The 24 innovators are Chefaa, DrugStoc, Field Inc, Figorr, Grinta, HealthPlus, Kasha, LifeBank, Maisha Meds, Meditect, mPedigree, MYDAWA, Pendulum, PharmaSecure, Remedial Health, RxAll, Sobrus, Sproxil, Talamus Health, VIA Global Health, Viebeg, Wingcopter, Yodawy and Zipline.

Speaking on the launch, Engagement Manager at Salient Advisory, Yomi Kazeem, said: ‘’The findings underscore the remarkable resilience and growing impact of African supply chain innovators. Having tracked health tech startups for many years, the emergence of a group of leading innovators is exciting to report. Local and global public health communities must increasingly recognize and leverage the innovators in developing reliable and resilient health supply chains.”

Senior Programme Officer at Gates Foundation, Ann Allen, said: “Technology-enabled innovations have the potential to help reverse long-running challenges in African health systems, while creating local jobs and strengthening local health markets. The report confirms innovators are increasingly positioned to deliver on this promise. However, there is more to be done as leveraging these innovations to truly transform cost-effective access for millions of un-served Africans will require concerted efforts from governments, industry and global health agencies alike.”

Funded by the Gates Foundation, the report entitled “Leading Innovations Enabling Health Product Access in Africa’’, finds that, amid difficult macro- economic realities and dwindling investment in African technology ecosystems, a select number of African health innovators are emerging as leaders.

Having operated for 10 years on average, the 24 leading innovators collectively now partner with over 100 manufacturers and 75 public health institutions, reaching around 50,000 providers, who serve hundreds of thousands of patients per day, and delivering health products to millions of consumers directly. Kasha made news capturing Series B investment last year, and has since gone on to build its health technology access platform and report yearly revenues of more than $50 million in 2023 – the highest ever recorded by Salient’s research to date.

Like Kasha, innovators that offer digitally-enabled Order and Inventory Management services to hospitals, clinics, pharmacies and drug shops appear dominant amongst the leading companies, making up 13 of the 24 featured innovations, with operations in 30 countries. Four leading Online Pharmacies are reaching nearly 10 million customers and generating median annual revenues of nearly $9m. The other categories featured are innovations in Product Protection and Visibility, Medical Drone Delivery and Data Analytics.

While leading innovators now appear positioned to deliver more substantive impact, they require targeted engagement from governments, donors, industry and global health institutions to transform access for un-served populations and improve the cost-effectiveness of care. To leverage leading innovators’ models in driving increases in access, governments, industry, donors and global health agencies should: simplify regulatory pathways; explore innovators’ ability to generate cost- savings for health systems, pursuing partnerships when the evidence is strong; and evolve contracting and payment systems to enable innovators to partner in healthcare delivery systems at larger scale.